Tian Lin
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Cancer-related gene regulation
Papers in
-
- RNA Research and Splicing 5
- RNA modifications and cancer 4
-
- Cancer-related molecular mechanisms research 7
- Cancer, Hypoxia, and Metabolism 3
- MicroRNA in disease regulation 2
- Co-authors
- Pingfu Hou (5 shared papers)Jin Bai (5 shared papers)Junnian Zheng (4 shared papers)Sen Meng (3 shared papers)Minle Li (3 shared papers)Sufang Chu (2 shared papers)Zhongwei Li (2 shared papers)Yuming Gu (1 shared paper)
- Journals
- International Journal of Biological Sciences (3 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Microbial Pathogenesis (1 paper)Advances in Clinical and Experimental Medicine (1 paper)Biomolecules & Therapeutics (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Tian Lin
20 papers receiving 710 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 336
- Molecular Biology 492
- Hepatology 31
- Oncology 89
- Immunology 61
Countries citing papers authored by Tian Lin
This map shows the geographic impact of Tian Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian Lin more than expected).
Fields of papers citing papers by Tian Lin
This network shows the impact of papers produced by Tian Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian Lin. The network helps show where Tian Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Tian Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 161 | |
| 2 | 2020 | 128 | |
| 3 | 2011 | 83 | |
| 4 | 2023 | 76 | |
| 5 | 2018 | 59 | |
| 6 | 2019 | 55 | |
| 7 | 2019 | 35 | |
| 8 | 2017 | 32 | |
| 9 | 2018 | 24 | |
| 10 | 2020 | 18 | |
| 11 | 2012 | 11 | |
| 12 | 2021 | 10 | |
| 13 | 2021 | 8 | |
| 14 | 2024 | 5 | |
| 15 | 2020 | 4 | |
| 16 | 2025 | 2 | |
| 17 | 2023 | 2 | |
| 18 | Study on the Relationship between Microvessel Density in Benign and Malignant Thyroid Nodules | 2012 | 1 |
| 19 | Prognostic significance of expression of CD133,VEGF and CD34 in hepatocellular carcinoma | 2013 | 1 |
| 20 | 2025 | 1 |
About Tian Lin
Tian Lin is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 23 papers that have together received 716 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), RNA Research and Splicing (5 papers), RNA modifications and cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), MicroRNA in disease regulation (2 papers), Gastric Cancer Management and Outcomes (2 papers), Peptidase Inhibition and Analysis (1 paper) and Hereditary Neurological Disorders (1 paper). The work is most often cited by research in Cancer Research (336 citations), Molecular Biology (492 citations), Hepatology (31 citations), Oncology (89 citations) and Immunology (61 citations). Tian Lin has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Pingfu Hou, Jin Bai, Junnian Zheng, Sen Meng, Minle Li, Sufang Chu, Zhongwei Li, Yuming Gu, Weihong Guo and Fengping Li. Their work appears in journals such as International Journal of Biological Sciences, Journal of Experimental & Clinical Cancer Research, Microbial Pathogenesis, Advances in Clinical and Experimental Medicine and Biomolecules & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.